Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 (PRISIT)
Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117--PRISIT Trial
Sponsor: Guangzhou University of Traditional Chinese Medicine
Listed as NCT03008798, this PHASE2 trial focuses on Occlusion and Stenosis of Unspecified Cerebral Artery and remains ongoing. Sponsored by Guangzhou University of Traditional Chinese Medicine, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Unknown PHASE2
-
Sep 2024 — Jan 2025 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Not Yet Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Nov 2019 — Jan 2020 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2018 — Nov 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Guangzhou University of Traditional Chinese Medicine
- Liaocheng People's Hospital
- Liaoning Cancer Hospital & Institute
- Zhongshan People's Hospital, Guangdong, China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.